• ‘Why not combine them?': Early dual biologic therapy may overcome limits in severe IBD

    7 days ago - By Healio

    DENVER - Early data suggest combination therapy with biologics or advanced small-molecules may be safe and effective in patients with inflammatory bowel disease, according to a presenter at the Crohn's and Colitis Congress.
    “We have all these different mechanisms of action right now - in newer development are some of the oral and p-19 ,” Edward V. Loftus Jr., MD, the Maxine and Jack Zarrow Family Professor of Gastroenterology at the Mayo Clinic in Rochester, Minnesota, told attendees. “We have all these different targets: Why not combine them?”
    Read more ...